Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 September 2007

Thorax. Published Online First: 27 March 2007. doi:10.1136/thx.2006.070847
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society.

Papers

The effect on patients with asthma of eradicating visible indoor mould - a randomised controlled trial

Michael L Burr 1*, Ian P Matthews 1, Robert A Arthur 1, Hannah L Watson 1, Clive Gregory 1, Frank D Dunstan 1 and Stephen R Palmer 1

1 Cardiff University, United Kingdom

* To whom correspondence should be addressed. E-mail: burrml{at}cf.ac.uk.

Accepted 27 February 2007


Abstract

Background It is not clear whether associations between respiratory symptoms and indoor mould are causal. Objective. A randomised controlled trial was conducted to see whether asthma improves when indoor mould is removed.

Methods Asthmatic patients' houses were randomly allocated into two groups. In one group, indoor mould was removed, fungicide was applied, and a fan was installed in the loft. In the control group, intervention was delayed for 12 months. At baseline, 6 months and 12 months questionnaires were administered and peak expiratory flow rate (PEFR) was measured.

Results Eighty-one houses were allocated to the intervention group and 83 to the control group; 95 participants in 68 intervention houses and 87 in 63 control houses supplied follow-up information. PEFR variability declined in both groups, with no significant differences between them. At 6 months, significantly more of the intervention group showed a net improvement in wheeze affecting activities (a difference of 25% between groups, 95% CI 3, 47; p=0.028), perceived improvement of breathing (52%, 95% CI 30, 74; p<0.0001) and perceived reduction in medication (59%, 95% CI 35, 81; p<0.0001). By 12 months the intervention group showed significantly greater reductions than the controls in preventer and reliever use, and improved more for rhinitis (24%, 95% CI 9, 39; p=0.001) and rhinoconjunctivitis (20%, 95% CI 5, 36; p=0.009).

Conclusions Although there was no objective evidence of benefit, symptoms of asthma and rhinitis improved and medication use declined following removal of indoor mould. It is unlikely that this was entirely a placebo effect.

Keywords: asthma, mould, rhinitis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Merkus, P J F M (2008). Mould eradication and asthma. Thorax 63: 385-385 [Full Text]  
  • Woodcock, A. (2007). Moulds and asthma: time for indoor climate change?. Thorax 62: 745-746 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs